{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:45:35Z","timestamp":1790484335180,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Gattefosse SAS"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jconrel.2019.08.008","type":"journal-article","created":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T12:32:08Z","timestamp":1565267528000},"page":"115-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":125,"special_numbering":"C","title":["Labrasol\u00ae is an efficacious intestinal permeation enhancer across rat intestine: Ex vivo and in vivo rat studies"],"prefix":"10.1016","volume":"310","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5834-7950","authenticated-orcid":false,"given":"Fiona","family":"McCartney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Jannin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Chevrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakime","family":"Boulghobra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delyan R.","family":"Hristov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Miolane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Chavant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Demarne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8781-8344","authenticated-orcid":false,"given":"David J.","family":"Brayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jconrel.2019.08.008_bb0005","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/nbt.4305","article-title":"Biopharmaceutical benchmarks","volume":"36","author":"Walsh","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2019.08.008_bb0010","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.addr.2016.06.005","article-title":"Intestinal permeation enhancers for oral peptide delivery","volume":"106","author":"Maher","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2019.08.008_bb0015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.addr.2016.02.004","article-title":"Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials","volume":"106","author":"Aguirre","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.jconrel.2019.08.008_bb0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S2213-8587(18)30372-3","article-title":"Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, Phase 2 trial","volume":"7","author":"Halberg","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.jconrel.2019.08.008_bb0025","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2019.2942","article-title":"Effect of additional oral semaglutide vs sitagliptin on glycated hemoglobin in adults with Type 2 diabetes uncontrolled with metformin alone or with sulfonylurea: the PIONEER 3 randomized clinical trial","author":"Rosenstock","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jconrel.2019.08.008_bb0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/pharmaceutics11020078","article-title":"Intestinal permeation enhancers for oral delivery of macromolecules: a comparison between salcaprozate sodium (SNAC) and sodium caprate (C10)","volume":"11","author":"Twarog","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2019.08.008_bb0035","article-title":"Successful development of oral SEDDS: screening of excipients from the industrial point of view","author":"Nardin","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.jconrel.2019.08.008_bb0040","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s13318-016-0374-x","article-title":"Absorption, distribution, metabolism, and excretion of the androgen receptor inhibitor, enzalutamide, in rats and dogs","volume":"42","author":"Ohtsu","year":"2017","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.jconrel.2019.08.008_bb0045","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijpharm.2003.11.013","article-title":"In situ intestinal absorption studies on low molecular weight heparin in rats using Labrasol as absorption enhancer","volume":"271","author":"Rama Prasad","year":"2004","journal-title":"Int. J.Pharm."},{"issue":"3","key":"10.1016\/j.jconrel.2019.08.008_bb0050","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/10611860290022688","article-title":"Absorption enhancing effect of labrasol on the intestinal absorption of insulin in rats","volume":"10","author":"Eaimtrakarn","year":"2002","journal-title":"J. Drug Target."},{"issue":"1","key":"10.1016\/j.jconrel.2019.08.008_bb0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejpb.2006.03.011","article-title":"Enhancing mechanism of Labrasol on intestinal membrane permeability of the hydrophilic drug gentamicin sulfate","volume":"64","author":"Koga","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.jconrel.2019.08.008_bb0060","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ijpharm.2009.06.018","article-title":"The effects of common solubilizing agents on the intestinal membrane barrier functions and membrane toxicity in rats","volume":"379","author":"Hamid","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2019.08.008_bb0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijpharm.2018.01.008","article-title":"Effects of surfactant-based permeation enhancers on mannitol permeability, histology, and electrogenic ion transport responses in excised rat colonic mucosae","volume":"539","author":"Maher","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.jconrel.2019.08.008_bb0070","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.xphs.2018.02.012","article-title":"Labrasol\u00ae and salts of medium-chain fatty acids can be combined in low concentrations to increase the permeability of a macromolecule marker across isolated rat intestinal mucosae","volume":"107","author":"Heade","year":"2018","journal-title":"J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.jconrel.2019.08.008_bb0075","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.bbalip.2007.02.009","article-title":"Comparative study on digestive lipase activities on the self emulsifying excipient Labrasol\u00ae, medium chain glycerides and PEG esters","volume":"1771","author":"Fernandez","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.jconrel.2019.08.008_bb0080","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1007\/s11095-013-1053-0","article-title":"In vitro digestion of the self-emulsifying lipid excipient Labrasol(\u00ae) by gastrointestinal lipases and influence of its colloidal structure on lipolysis rate","volume":"30","author":"Fernandez","year":"2013","journal-title":"Pharm. Res."},{"issue":"10","key":"10.1016\/j.jconrel.2019.08.008_bb0085","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1007\/s11095-016-1975-4","article-title":"An assessment of the permeation enhancer, 1-phenyl-piperazine (PPZ), on paracellular flux across rat intestinal mucosae in Ussing chambers","volume":"33","author":"Bzik","year":"2016","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2019.08.008_bb0090","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ijpharm.2015.09.009","article-title":"Development of self emulsifying lipid formulations of BCS class II drugs with low to medium lipophilicity","volume":"495","author":"Jannin","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.jconrel.2019.08.008_bb0095","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.ejpb.2014.10.013","article-title":"Investigation of coco-glucoside as a novel intestinal permeation enhancer in rat models","volume":"88","author":"Aguirre","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4\u20135","key":"10.1016\/j.jconrel.2019.08.008_bb0100","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.ejps.2013.01.009","article-title":"Colonic absorption of salmon calcitonin using tetradecyl maltoside (TDM) as a permeation enhancer","volume":"48","author":"Petersen","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.jconrel.2019.08.008_bb0105","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1021\/mp500776a","article-title":"Interaction with mixed micelles in the intestine attenuates the permeation -enhancing potential of alkyl-maltosides","volume":"12","author":"Gradauer","year":"2015","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/j.jconrel.2019.08.008_bb0110","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1007\/s11095-014-1303-9","article-title":"Novel suspension formulation enhances intestinal absorption of macromolecules via transient and reversible transport mechanisms","volume":"31","author":"Tuvia","year":"2014","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.jconrel.2019.08.008_bb0115","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0939-6411(02)00116-9","article-title":"In vitro and in situ evidence for the contribution of Labrasol and Gelucire 44\/14 on transport of cephalexin and cefoperazone by rat intestine","volume":"54","author":"Koga","year":"2002","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.jconrel.2019.08.008_bb0120","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ejpb.2014.10.008","article-title":"A head-to-head multi-parametric high content analysis of a series of medium chain fatty acid intestinal permeation enhancers in Caco-2 cells","volume":"88","author":"Brayden","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1-2","key":"10.1016\/j.jconrel.2019.08.008_bb0125","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ijpharm.2016.09.016","article-title":"Hydrodynamic size characterization of a self-emulsifying lipid pharmaceutical excipient by Taylor dispersion analysis with fluorescent detection","volume":"513","author":"Chamieh","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.jconrel.2019.08.008_bb0130","doi-asserted-by":"crossref","first-page":"408S","DOI":"10.1042\/bst023408s","article-title":"Inhibition of dietary cholesterol ester absorption by 3-BCP, a suicide inhibitor of cholesterol-esterase","volume":"23","author":"Bailey","year":"1995","journal-title":"Biochem. Soc. Trans."},{"issue":"8","key":"10.1016\/j.jconrel.2019.08.008_bb0135","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.7164\/antibiotics.40.1081","article-title":"Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity","volume":"40","author":"Weibel","year":"1987","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.jconrel.2019.08.008_bb0140","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ijpharm.2019.02.014","article-title":"SEDDS for intestinal absorption of insulin: Application of Caco-2 and Caco-2\/HT29 co-culture monolayers and intra-jejunal instillation in rats","volume":"560","author":"Liu","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2019.08.008_bb0145","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ejps.2005.01.001","article-title":"Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells","volume":"24","author":"Sha","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.jconrel.2019.08.008_bb0150","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejps.2009.09.001","article-title":"Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae","volume":"38","author":"Maher","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2019.08.008_bb0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4155\/tde.10.5","article-title":"Restoration of rat colonic epithelium after in situ intestinal instillation of the absorption promoter, sodium caprate","volume":"1","author":"Wang","year":"2010","journal-title":"Ther. Deliv."},{"issue":"7","key":"10.1016\/j.jconrel.2019.08.008_bb0160","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1080\/00365520310003101","article-title":"Applicability of the Ussing chamber technique to permeability determinations in functionally distinct regions of the gastrointestinal tract in the rat","volume":"38","author":"Bajka","year":"2003","journal-title":"Scand. J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.jconrel.2019.08.008_bb0165","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1023\/A:1015854127486","article-title":"S, Awazu, Differences in the enhancing effects of sodium caprate on colonic and jejunal drug absorption","volume":"9","author":"Tomita","year":"1992","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.jconrel.2019.08.008_bb0170","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ejps.2012.08.010","article-title":"Evaluation of alkylmaltosides as intestinal permeation enhancers: Comparison between rat intestinal mucosal sheets and Caco-2 monolayers","volume":"47","author":"Petersen","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2019.08.008_bb0175","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijpharm.2016.11.063","article-title":"Exploring gastrointestinal variables affecting drug and formulation behavior: Methodologies, challenges and opportunities","volume":"519","author":"Hens","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2019.08.008_bb0180","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jconrel.2018.07.045","article-title":"Physicochemical, pharmacokinetic and pharmacodynamic analyses of amphiphilic cyclodextrin-based nanoparticles designed to enhance intestinal delivery of insulin","volume":"286","author":"Presas","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.08.008_bb0185","article-title":"Sucrose laurate is an effective permeation enhancer for for insulin: rat intestinal instillations","volume":"44","author":"McCartney","year":"2017","journal-title":"Proc. Intern. Symp. Control. Rel. Bioact. Mater."},{"issue":"28","key":"10.1016\/j.jconrel.2019.08.008_bb0190","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1073\/pnas.1722338115","article-title":"Ionic liquids for oral insulin delivery","volume":"115","author":"Banerjee","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2019.08.008_bb0195","doi-asserted-by":"crossref","DOI":"10.1007\/s40262-019-00772-2","article-title":"The effect of food intake on the pharmacokinetics of oral basal insulin: a randomised crossover","author":"Halberg","year":"2019","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.jconrel.2019.08.008_bb0200","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2016.1176822","article-title":"Safety concerns over the use of intestinal permeation enhancers: a mini-review","volume":"4","author":"McCartney","year":"2016","journal-title":"Tissue Barriers"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919304729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919304729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:42:38Z","timestamp":1759160558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365919304729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":40,"alternative-id":["S0168365919304729"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.08.008","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Labrasol\u00ae is an efficacious intestinal permeation enhancer across rat intestine: Ex vivo and in vivo rat studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}